Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Specialist – QOP Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist - Supply Operations Hyderabad (Office) India Operations Innovative Medicines Technical Operations Sep 03, 2024
Specialist - Quality Operations (APQR) INSURGENTES Mexico Operations Innovative Medicines Quality Sep 27, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Oct 23, 2024
Specialist - QA Ops - Manufacturing Mgmt Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 03, 2024
Specialist - QA Ops - Manufacturing Mgmt Tuas South Avenue Singapore Operations Innovative Medicines Quality Sep 03, 2024
Specialist - Product Complaints - QOP Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Specialist - MS&T Hyderabad (Office) India Operations Innovative Medicines Technical Operations Oct 22, 2024
Specialist - Mobile Device Management (MDM) Engineer Prague Czech Republic Operations CTS Technology Transformation Jul 17, 2024
Specialist - Master Data Management Hyderabad (Office) India Operations Innovative Medicines Technical Operations Jul 26, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 03, 2024
Spec. DDIT ISC QNova Hyderabad (Office) India Operations CTS Technology Transformation Sep 30, 2024
Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation Apr 24, 2024
Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation May 07, 2024
Spec. DDIT IES CIS Security Hyderabad (Office) India Operations CTS Technology Transformation Oct 03, 2024
Sourcing Manager R&D, Drug Development Hyderabad (Office) India Operations CTS Procurement Jun 04, 2024
Sourcing Manager R&D Prague Czech Republic Operations CTS Procurement Jul 26, 2024
Sourcing Manager MRO Warsaw Poland Operations Innovative Medicines Procurement Oct 02, 2024
Solution Design Associate Director Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 09, 2024
Solution Design Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Sep 03, 2024
Solution Delivery- SAP SME (BTP & CPI) Prague Czech Republic Operations CTS Technology Transformation Oct 10, 2024
Solution Delivery Architect Global Clinical Operations Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 15, 2024
Solution & Service Design Manager London (The Westworks) United Kingdom International Innovative Medicines Market Access Aug 15, 2024
Snr.Spec. DDIT APD Sol Del Visualization Hyderabad (Office) India Operations CTS Technology Transformation Apr 22, 2024
Snr. Specialist, IT Business Analyst - Regulatory Affairs Barcelona Gran Vía Spain Operations CTS Technology Transformation Aug 13, 2024
Snr. Specialist SAP BASIS / AWS Cloud INSURGENTES Mexico Operations CTS Technology Transformation Sep 30, 2024
Snr. Specialist MDM (Master Data Management - implementation using Reltio) Hyderabad (Office) India Operations CTS Technology Transformation Aug 28, 2024
Snr. Spec. DDIT ISC IES Hyderabad (Office) India Operations CTS Technology Transformation May 14, 2024
Snr Specialist(Power BI) Hyderabad (Office) India Operations CTS Technology Transformation Oct 25, 2024
Snr Specialist(Power BI & Embedded Analytics - Web applications) Hyderabad (Office) India Operations CTS Technology Transformation Aug 28, 2024
Snr Specialist, IT Business Analyst, Technical Design (Regulatory Affairs) Barcelona Gran Vía Spain Operations CTS Technology Transformation Aug 13, 2024
Snr Spec. DDIT US&I D&A Operations Hyderabad (Office) India Operations CTS Technology Transformation Apr 30, 2024
SMR Fuzhou (Fujian Province) China International Innovative Medicines Sales May 28, 2024
Skladiščnik (m/ž/d) Ljubljana Slovenia Operations Innovative Medicines Technical Operations Oct 25, 2024
Skladiščnik (m/ž/d) Mengeš Slovenia Operations Innovative Medicines Technical Operations Oct 17, 2024
Site Quality Head, Indianapolis Isotopes Site Indianapolis USA Operations Innovative Medicines Quality Oct 23, 2024
Site Operations Lead Selangor Malaysia Operations CTS BD&L & Strategic Planning Oct 08, 2024
Site Head – Biomedical Research India Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Oct 17, 2024
Site Finance Head Morris Plains USA Finance Innovative Medicines Audit & Finance Oct 04, 2024
Site Equipment & CQV Lead Indianapolis USA Operations Innovative Medicines Technical Operations Sep 03, 2024
Site Engineering Head / Directeur Ingénierie et Maintenance (m/f/d) Huningue France Operations Innovative Medicines Technical Operations Sep 03, 2024
Site Engineering Head Millburn USA Operations Innovative Medicines Technical Operations Aug 23, 2024
Senior/Advanced Medical/Sales Representative Beijing (Beijing) China International Innovative Medicines Sales Aug 06, 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales Jun 04, 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales Jun 04, 2024
Senior/Advanced Medical/Sales Representative Beijing (Beijing) China International Innovative Medicines Sales Aug 06, 2024
Senior/Advanced Medical/Sales Representative Zhangzhou (Fujian Province) China International Innovative Medicines Sales Jun 04, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only